Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2020 Jul 6;13(8):e008160. doi: 10.1161/CIRCEP.119.008160

Table 1.

Clinical Demographics

Entire Cohort (n=35) Training (n=20) Validation (n=5) Testing (n=10) P-Value
Age (years) 65 ± 9.3 66 ± 9.3 64 ± 10.0 65 ± 10.0 0.941
Male N (%) 23 (66%) 12 (60%) 3 (60%) 8 (80%) 0.530
Persistent AF N (%) 35 (100%) 20 (100%) 5 (100%) 10 (100%) 1.000
Prior AF Ablation N (%) 16 (46%) 10 (50%) 3 (60%) 3 (30%) 0.460
AF History (days) 96 [31–133] 100 [38–130] 47 [28–734] 120 [15–830] 0.544
Hypertension N (%) 22 (63%) 13 (65%) 3 (60%) 6 (60%) 0.955
LA diameter (mm) 46 ± 8.1 45 ± 9.6 51 ± 5.3 47 ± 4.7 0.494
LV ejection fraction (%) 55 ± 10 56 ± 10 48 ± 8.8 57 ± 9.1 0.235
CHADSVASc score 2 ± 1.3 2 ± 1.4 2 ± 2.1 2 ± 1.2 0.999
Coronary disease N (%) 6 (17%) 4 (20%) 1 (20%) 1 (10%) 0.778
*

Values are mean ± SD, median [quartiles], or N (%)